Abstract:ABO/RhD blood group matching is considered an important factor in hematopoietic stem cell transplantation (HSCT) since ABO incompatibility may affect the engraftment and/or ABO expressed on recipient endothelial cells may represent targets for graft versus host disease. The CCR5 deletion (CCR5Δ32) is associated with HIV resistance and provides a therapeutic strategy for eradicating HIV infection in HIV+ patients undergoing HSCT. Currently, HLA typing of NMDP donors is performed on DNA isolated from buccal swabs. The goal of this study was to develop molecular typing methods for ABO/RhD and CCR5Δ32 for HSCT registry donors. 96 reference buccal swab samples were obtained from NMDP. The SSP typing for ABO/RhD and CCR5Δ32 were performed using a multiplex PCR (One Lambda) and the sizes of the amplicons were detected on 3730xl DNA Analyzer and interpreted with Gene Mapper 5. ABO typing was performed by NGS using in-house primers on Illumina MiSeq system and the results were analyzed using Galaxy (UCLA). For ABO blood group typing, both SSP and NGS typing methods yielded 100% concordance with reference in all major blood groups (A = 29.2%, B = 20.8%, AB = 20.8%, O = 29.2% respectively) and differentiated A1 and A2 subtypes. NGS typing identified a total of 4 A alleles, 1 B allele, and 10 O alleles with 7 novel mutations. Two mutations occurred in B101 (A930G) and O02 (G1105A). We discerned 7 O alleles without the nt261G deletion which included 5 O03 and 2 O49 alleles. O03 and O49 alleles have G802A compared to A101 which presumably inactivates the enzyme by altering its sugar-binging sites. In addition, the G1096A novel mutation was detected in all 5 O03 alleles. 100% concordance was achieved for RhD typing with 23 (24%) RhD- homozygous samples detected. In this cohort, no CCR5Δ32 double deletion was detected, but 13 CCR5Δ32/CCR5 heterozygous were found (13.5%). The CCR5Δ32 typing was confirmed by in-house SSP with 100% concordance. We demonstrate the ability to perform accurate molecular tying of blood group ABO/RhD and CCR5Δ32. Successful molecular typing of registry donors for ABO/RhD and CCR5Δ32 may reduce donor search time and time to transplant. In addition, the ability to identify novel/rare alleles can fill in gaps in knowledge of the existing blood antigen registry and further improve the HSCT outcome.

Molecular genotyping versus serological diagnosis for RH blood group typing in sickle cell patients

Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice

RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA

Clinical Significance of Screening of Rh-negative Blood Group and Detection of Irregular Antibody

Molecular Basis of ABO Variants Including Identification of 16 Novel ABO Subgroup Alleles in Chinese Han Population

Frequency of Kell and Rh alloantibodies in Iranian Thalassemia Patients in Khorasan Razavi Province, Iran

Prevalence of Red Blood Cell Alloimmunization Among Pediatric Patients With Sickle Cell Disease in Saudi Arabia

Red Cell Alloimmunisation Among Sickle Cell Disease and Thalassemia Patients Following Rh- and K-Matched Red Cell Transfusion in Southwestern Saudi Arabia: A Multicenter Study

Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited

OR28 Advances in Molecular Typing of Abo/rhd and Ccr5δ32 Mutation

Rh and Kell phenotyping in voluntary blood donors: A study from a tertiary care blood center of western India

Performance evaluation of the Hemotype SCTM rapid test for the diagnosis of sickle cell disease

Frequency of Duffy, Kidd, Lewis, and Rh Blood Group Antigens and Phenotypes Among Donors in the Al-Ahsa Region, Saudi Arabia

Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia

Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation

Resolution of RHCE Haplotype Ambiguities in Transfusion Settings

Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako

Red cell alloantibodies in beta-thalassaemia major patients' blood referring to the regional blood transfusion center of Tehran, Iran

[The application of PCR-SSP with the serology in identification and genotyping of ABO ambiguous blood group]

Analysis of Rhesus (Rh) Antigen Distributions in Donors and Multi-transfused Patients for Phenotype-Matched Transfusion

Accuracy of RHC/c genotyping in Chinese Han population